Eli Lilly Shocks Wall Street: Global Demand for Weight-Loss Drugs Sends Forecast Soaring!
Practical: AI & Business News · Practical News
Audio is streamed directly from the publisher (content.rss.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Eli Lilly has raised its full-year forecast after unprecedented international demand for its hit weight-loss and diabetes drugs, Mounjaro and Zepbound. The pharmaceutical giant’s booming sales and rapid global expansion signal a new era for obesity treatment worldwide.
Get the top 40+ AI Models for $20 at AI Box: https://aibox.ai
AI Chat YouTube Channel: https://www.youtube.com/@JaedenSchafer
Join my AI Hustle Community: https://www.skool.com/aihustle
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.